Global Medical Research - M3 WR

Dallas, Texas 75224-2367

0 studies enrolling now · 2 studies all time

What they study most

Primary IgA Nephropathy, SARS-CoV-2 Infection

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression — Recruiting now
• Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection — Completed